Company Filing History:
Years Active: 2006-2007
Title: Thomas Serwold: Innovator in Immune Response Modulation
Introduction
Thomas Serwold is a notable inventor based in El Cerrito, California. He has made significant contributions to the field of immunology, particularly in the modulation of immune responses. With a total of 2 patents, his work focuses on innovative methods to enhance immune system functionality.
Latest Patents
One of Thomas Serwold's latest patents involves the use of ERAAP modulators to regulate immune responses. This patent describes a method for modulating an immune response by selectively inhibiting ERAAP, which stands for ER aminopeptidase associated with antigen processing. The method includes contacting a patient in need of immune response modulation with a physiologically acceptable dosage composition that contains an effective amount of an inhibitor of ERAAP activity. The patent confirms that this approach results in the inhibition of ERAAP activity and a subsequent modulation of the immune response in the patient. Various selective inhibitors have been identified as effective, including amino thiols like leucine thiol, ERAAP-specific antibody complementarity-determining regions, and ERAAP-specific siRNA.
Career Highlights
Thomas Serwold is affiliated with the University of California, where he continues to advance research in immunology. His work has garnered attention for its potential applications in therapeutic settings, particularly for patients requiring immune system interventions.
Collaborations
One of his notable collaborators is Nilabh Shastri, with whom he has worked on various projects related to immune response modulation.
Conclusion
Thomas Serwold's innovative work in the field of immunology, particularly through his patents on ERAAP modulators, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the way immune responses are managed in clinical settings.